---
$id: https://graph.org.ai/products/commodity/51131506
$type: Product
source: UNSPSC
code: "51131506"
title: "Erythropoietin"
class: "51131500"
classTitle: "Antianemic drugs"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erythropoietin

**UNSPSC Code**: 51131506
**Class**: [Antianemic drugs](Antianemic drugs.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a chemotherapy regimen used to treat non-hodgkins lymphoma with the molecular formula C809H1301N229O240S5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 64FS3BFH5W, more generally known as erythropoietin. European Medicines Agency schedules erythropoietin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06575MIG. The term ERYTHROPOIETIN is an International Non-Proprietary Name or INN. As of Q4 2014, ERYTHROPOIETIN remains the US FDA Preferred Term for this commodity. Erythropoietin bears US NLM identifiers UMLS ID C0014822 and NCI Concept Code C20429. SMILES: NONE.

